Lunai Bioworks (LNAI) Goodwill & Intangibles (2012 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Goodwill & Intangibles of $119115.0 in Q1 2026, down 16.17% quarter-over-quarter from $142096.0 in Q4 2025, and up 636.55% on a YoY basis from $16172.0 in Q1 2025.
Lunai Bioworks (LNAI) Goodwill & Intangibles (2012 - 2026) Analysis & Trends
Lunai Bioworks' Goodwill & Intangibles history runs 15 years deep, the most recent figure standing at $119115.0 for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 636.55% year-over-year to $119115.0; the TTM figure through Mar 2026 stood at $119115.0 (up 636.55% YoY), while the FY2025 annual figure was $165994.0, up 452.52% from the prior year.
- Goodwill & Intangibles was $119115.0 for Q1 2026 at Lunai Bioworks, down from $142096.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $339.1 million in Q1 2024 to a low of $16172.0 in Q1 2025.
- Historically, Goodwill & Intangibles has averaged $38.4 million across 5 years, with a median of $152980.0 in 2025.
- Biggest YoY gain for Goodwill & Intangibles was 695.92% in 2025; the steepest drop was 100.0% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $11.6 million in 2022, then surged by 466.07% to $65.9 million in 2023, then plunged by 99.97% to $17853.0 in 2024, then surged by 695.92% to $142096.0 in 2025, then decreased by 16.17% to $119115.0 in 2026.
- The last three Goodwill & Intangibles figures came in at $119115.0 (Q1 2026), $142096.0 (Q4 2025), and $152980.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119,115.00 |
| Dec 31, 2025 | 142,096.00 |
| Sep 30, 2025 | 152,980.00 |
| Jun 30, 2025 | 165,994.00 |
| Mar 31, 2025 | 16,172.00 |
| Dec 31, 2024 | 17,853.00 |
| Sep 30, 2024 | 28,750.00 |
| Jun 30, 2024 | 30,043.00 |
| Mar 31, 2024 | 339.13 Mn |
| Dec 31, 2023 | 65.89 Mn |
| Sep 30, 2023 | 65.89 Mn |
| Jun 30, 2023 | 39,676.00 |
| Mar 31, 2023 | 73.21 Mn |
| Dec 31, 2022 | 11.64 Mn |
| Sep 30, 2022 | 84.85 Mn |
| Jun 30, 2022 | 44,268.00 |
| Mar 31, 2022 | 11.69 Mn |
| Dec 31, 2021 | 166.46 Mn |
| Sep 30, 2021 | 11.70 Mn |
| Jun 30, 2021 | 11.71 Mn |